Headache Clinical Trial
— PRAOfficial title:
Posture-related Headache: Profile Analysis and Intervention
| NCT number | NCT02887638 |
| Other study ID # | PHA-2016 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 8, 2018 |
| Est. completion date | May 18, 2020 |
| Verified date | May 2020 |
| Source | Hasselt University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Diagnosing and treating posture-related headache (PRH), such as tension-type and cervicogenic
headache, is seriously hampered because of common features and complex interaction of the
neurological and musculoskeletal system. Current therapies are therefore not as effective and
the population of patients with PRH keeps on increasing. The diagnostic as well as the
therapeutic process need more structure in order to select the most effective treatment;
thereby contributing to preventive measures. This goal can be achieved through fundamental
research with a clinically oriented background. Our study starts from a clinical problem,
with a growing incidence, and is therefore highly relevant. Because sitting-posture seems to
play an important role in PRH, the first step in the diagnostic process is to analyse
postural differences between a PRH- and a control-group. In addition, the role of the dura
mater in the headache-process will be examined. Patients with PRH will be classified in
homogeneous groups based on these results. In a second phase individual-specific treatment
programs will be composed. The general treatment-approach of postural abnormalities in the
past failed because of the heterogeneous patient-populations. Sub-classifying musculoskeletal
problems has been proven to be successful in the past (O'Sullivan & Dankaerts, non-specific
low back pain).
Our study is divided in 2 phases:
- phase 1: profile analysis (no intervention, experimental headache-group vs. asymptomatic
controls)
- phase 2: interventional phase (clustered headache-groups, based on the results of phase
1
| Status | Completed |
| Enrollment | 36 |
| Est. completion date | May 18, 2020 |
| Est. primary completion date | May 18, 2020 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 20 Years to 50 Years |
| Eligibility |
Inclusion Criteria Headache-group: 1. Males and females between 20 and 50 years 2. Confirmed medical diagnosis of tension-type headache, cervicogenic headache or a mixture 3. Headache can be provoked by awkward cervical and/or head postures Exclusion Criteria Headache-group: 1. Pregnancy 2. History of pericranial surgery 3. Serious pathology (neurological/cardiovascular/endocrine/musculoskeletal) 4. Red flags 5. Physical or manual therapy treatment for headache < 4 weeks prior the study 6. Excessive (> 10 days/month for > 3 months) use of: ergotamine, NSAID's, opioids, triptans, acetylsalicylic acid and simple analgesics 7. Psychiatric comorbidity 8. Visual or temporo-mandibular dysfunction Inclusion Criteria Control-group: 1. Males and females between 20 and 50 years 2. Asymptomatic, no headache-history Exclusion Criteria Control-group: 1. Pregnancy 2. History of pericranial surgery 3. Excessive (> 10 days/month for > 3 months) use of: ergotamine, NSAID's, opioids, triptans, acetylsalicylic acid and simple analgesics 4. Visual or temporo-mandibular dysfunction |
| Country | Name | City | State |
|---|---|---|---|
| Belgium | Ziekenhuis Oost-Limburg | Genk | |
| Belgium | Jessa Ziekenhuis | Hasselt | |
| Belgium | Leuven University | Leuven | |
| Netherlands | Zuyd University | Heerlen | |
| Netherlands | Orbis Medisch Centrum | Sittard |
| Lead Sponsor | Collaborator |
|---|---|
| Hasselt University | Algemeen Ziekenhuis Vesalius, Jessa Hospital, KU Leuven, Orbisch Medisch Centrum, Ziekenhuis Oost-Limburg, Zuyd University of Applied Sciences |
Belgium, Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Sitting-posture-profile | Sitting-posture will be measured with a 3D-video analysis (Bonita, ©Vicon Motion Systems Ltd. UK). Markers are placed on specific anatomical reference points on the participant. Afterwards angles (°) will be automatically calculated (Nexus, ©Vicon Motion Systems Ltd. UK) | day 1 | |
| Primary | Pain-Profile | 'Pain Pressure Threshold' will be measured. Through pressure- algometry (a) 'Pressure Pain Detection Threshold' (kPa/cm²) and (b) 'Pressure Pain Tolerance' (sec) will be determined (Somedic Sales AB, Stockholm Sweden). | day 1 | |
| Primary | Sitting-posture-profile | Sitting-posture will be measured with a 3D-video analysis (Bonita, ©Vicon Motion Systems Ltd. UK). Markers are placed on specific anatomical reference points on the participant. Afterwards angles (°) will be automatically calculated (Nexus, ©Vicon Motion Systems Ltd. UK) | week 1 up to week 8 | |
| Secondary | Headache-related medication-use, headache intensity, duration and frequency. | Through the use of a specific diary the secondary outcomes will be evaluated. | week -4 up to week 8 | |
| Secondary | Impact of headache on the quality of life. | The 'Headache Impact Test (HIT-6)' will be used. | week -4 up to week 8 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03472872 -
A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
|
Phase 4 | |
| Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
| Withdrawn |
NCT02866084 -
Neuromodulation Treatment of Vestibular Migraines
|
N/A | |
| Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
| Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
| Not yet recruiting |
NCT04352218 -
Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache
|
Phase 2 | |
| Completed |
NCT02734992 -
Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers
|
N/A | |
| Completed |
NCT01327118 -
Prostaglandin F2alpha in a Human Headache Model
|
N/A | |
| Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
| Not yet recruiting |
NCT00969995 -
Identification of Inflammatory Markers in Migraine Patients
|
N/A | |
| Not yet recruiting |
NCT00752921 -
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache
|
Phase 4 | |
| Completed |
NCT00212810 -
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
|
Phase 4 | |
| Terminated |
NCT00291395 -
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00263094 -
An End to the Yom Kippur (and Ramadan) Headache
|
N/A | |
| Completed |
NCT00135122 -
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
|
Phase 3 | |
| Completed |
NCT02475005 -
An Intervention to Improve Adolescent Headache Self-management
|
N/A | |
| Completed |
NCT03163901 -
The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury
|
N/A | |
| Completed |
NCT01664585 -
Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life
|
N/A | |
| Completed |
NCT04632420 -
Evaluation of Headache and Childbirth in a Chronic Pain Population
|
||
| Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|